Persistent atrial fibrillation is associated with a poor prognosis in patients with atrioventricular block and

Dubravko Petrač1, Vjekoslav Radeljić, Diana Delić-Brkljačić

  • 1Bogdan Cardiology Polyclinic, Zagreb, Croatia. d.petrac@inet-hr

Insights

Persistent atrial fibrillation (AF) in patients with AV block and DDD pacemakers increases cardiovascular death risk, particularly from heart failure. This finding highlights the importance of monitoring for AF in this patient population.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Research

Background:

  • Prognostic impact of persistent atrial fibrillation (AF) in patients with atrioventricular (AV) block and dual chamber (DDD) pacemakers is understudied.
  • Investigating the influence of persistent AF on clinical outcomes in this specific patient group.

Purpose of the Study:

  • To determine if persistent AF development impacts clinical outcomes in patients with AV block and DDD pacemakers.

Main Methods:

  • Retrospective analysis of 308 patients with AV block and DDD pacemakers followed for 36 months.
  • Comparison of clinical outcomes between 34 patients with persistent AF and 278 patients without persistent AF.
  • Primary outcome assessed was cardiovascular death.

Main Results:

  • Higher incidence of cardiovascular death in the persistent AF group (6.8% per year) versus the control group (2.9% per year; P=0.028).
  • Increased heart failure-related deaths (P=0.009) and hospitalizations for heart failure (P=0.008) in the persistent AF group.
  • No significant difference in nonfatal stroke risk between groups (P=0.628).

Conclusions:

  • Development of persistent AF in patients with AV block and DDD pacemakers is linked to elevated cardiovascular death risk.
  • Persistent AF is associated with an increased risk of heart failure and related mortality in this population.
Abstract

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...